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Abstract
Objective Antibiotics are the most commonly prescribed
drugs used by children. Excessive and irrational use of
antibiotic drugs is a world-wide concern. We performed a
drug utilization study describing the patterns of antibiotic
use in children aged 0–19 years between 1999 and 2005 in
the Netherlands.
Methods We used IADB.nl, a database with pharmacy drug
dispensing data covering a population of 500,000 people and
investigated all prescriptions of oral antibiotic drugs (ATC
J01) for children ≤19 years between 1999 and 2005.
Results The total number of antibiotic prescriptions per
1000 children per year ranged from 282 in 2004 to 307 in
2001 and did not change between years during the study
period in a clinically relevant way. The prevalence of
receiving at least one prescription varied between 17.8% in
2004 and 19.3% in 2001. Amoxicillin was the most
frequently prescribed drug (46.4% of all antibiotic pre-
scriptions in 1999 and 43.2% in 2005). Between 1999 and
2005 there was a shift from the small-spectrum phenethi-
cillin, a penicillin preparation [ratio 2005/1999 0.76; 95%
confidence interval (CI) 0.72–0.81], to amoxicillin/clavu-
lanic acid (ratio 2005/1999 1.70; 95% CI 1.61–1.79) and
from the old macrolide erythromycin (ratio 2005/1999 0.35;
95% CI 0.32–0.39) to the new macrolide antibiotic
azithromycin (ratio 2005/1999 1.78; 95% CI 1.65–1.92).
Conclusion The use of antibiotic drugs in treating children
in the Netherlands is comparable to that in other northern
European countries. Broad-spectrum antibiotics were pre-
scribed more frequently than recommended by the guide-
lines and increased during our study period. Initiatives to
improve guideline-directed antibiotic prescribing are
strongly recommended.
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Introduction
Antibiotics are the most commonly prescribed drugs for
children. A Dutch study reported that 21% of all children
registered in a prescription database used at least one
antibiotic drug in 1998 [1].
Excessive and irrational use of antibiotic drugs is a
world-wide concern because of the development of bacte-
rial resistance [2, 3]. Many antibiotic drugs are prescribed
for respiratory tract infections even though these infections
are known to be predominantly viral [4]. A Dutch
epidemiological case-control study found that viruses were
detected in 58% of patients with acute respiratory tract
infections [5]. In a study investigating pharyngitis in
children, researchers were unable to isolate bacteria from
their throats of 74% of the children studied, making
antibiotic treatment of this group unnecessary [6].
The Netherlands healthcare profession has a reputation
for showing restraint in prescribing antibiotics. Two drug
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utilization studies based on national administrative data
have confirmed this—relative to other European countries,
the Netherlands prescribes the lowest amount of antibiotic
drugs. [2, 7, 8].
This being said, little is known about antibiotic use in
Dutch children. A national survey among Dutch general
practitioners (GPs) in 1987 and 2001 concluded that the
number of prescriptions written for broad-spectrum anti-
biotics prescriptions based on inappropriate diagnoses in
children had increased [9]. Another study examining the
treatment of respiratory tract infections reported that
antibiotic drugs were prescribed in 35% of the episodes in
children aged 0–5 years [10].
These studies demonstrate the need for further investi-
gation into how antibiotic drug prescribing for Dutch
children corresponds to evidence-based medicine in order
to motivate improvements in prescribing. To this end, we
performed a drug utilization study of antibiotic use in
children aged 0–19 years from 1999 till 2005, investigating
prevailing patterns in prescribing specific, frequently
prescribed antibiotics as well as relating these patterns to
the Dutch guidelines.
Methods
The data in this study are derived from IADB.nl (http://
www.IADB.nl), a database containing pharmacy dis-
pensing data from the Netherlands. IADB.nl covers a
population of approximately 500,000 people and is rep-
resentative of the Dutch population in terms of drug use.
The percentage of children aged 0–19 in the database was
stable in the study period (1999–2005) and varied from
22.8 to 23.2%.
The data assembled in IADB.nl are derived from 55
community pharmacies. Each prescription filled by these
pharmacies, whether prescribed by GPs or specialist, is
included in the database, regardless of reimbursement
status. Dutch patients mainly obtain their drugs from their
own local pharmacy, so the medication histories in IADB.nl
are quite complete.
In this study we investigated all prescriptions of systemic
antibiotic drugs [Anatomical Therapeutical Chemical
(ATC) classification-code J01 [11]) prescribed between
1999 and 2005 for children under the age of 20.
In the Netherlands, pharmacies deliver precisely the
number of tablets prescribed for an antibiotic treatment
course; if necessary, packages are opened and the exact
number of tablets prescribed are delivered to the patient. An
antibiotic is supplied for a maximum of 14 days. Taking
these two facts into account, we assumed that one
prescription represents one course of antibiotic drug.
We also determined the number of prescriptions per
1000 children per month and per year.
The yearly prevalence of antibiotic use was defined as
the percentage of children who received at least one
prescription per year. In order to compare the use of
specific antibiotic drugs in1999 to that in 2005 we
calculated the proportion of those antibiotics prescribed
from among the total number of antibiotic prescriptions in
both years. We also calculated the ratio of the number of
prescriptions per 1000 children in 2005 compared to 1999
(ratio 2005/1999) with a 95% confidence interval (CI).
These calculations were stratified for different age catego-
ries (0–4, 5–9, 10–14 and 15–19) and sex.
The numbers of the whole population used were based
on general population statistics, using figures from Statis-
tics Netherlands. We used the program Microsoft EXCEL ver.
2003 to analyze the results.
The guidelines used are the Standards of the Dutch
College of General Practitioners (NHG [12]) and the local
‘Groninger Formularium’ (GF [13]) developed by GPs and
pharmacists. The latter guideline covers the main part of the
population studied.
Results
We found that 234,891 prescriptions of systemic antibiotic
drugs had been prescribed from 1999 to 2005 for children
aged ≤19 years. The number of prescriptions per 1000
children per year ranged from 282 in 2004 to 307 in 2001
and did not change between years in a clinically relevant
way. The yearly prevalence of antibiotic use in children
varied between 17.8% in 2004 and 19.3% in 2001.
The monthly number of prescriptions per 1000 children
fluctuated from 17 (August 2000) to 40 (December 2004),
showing a peak in the winter months and a nadir in the
summer months.
Amoxicillin, amoxicillin with clavulanic acid, clarithro-
mycin, phenethicillin, trimethoprim, cotrimoxazole (sulfa-
methoxazole/ trimethoprim), erythromycin, doxycyclin,
nitrofurantoin, azithromycin and flucloxacillin were the most
frequenly prescribed antibiotics (Fig. 1), with amoxicillin
being prescribed more frequently than any of the other
antibiotic drugs. The use of azithromycin, amoxicillin with
clavulanic acid, flucloxacillin, clarithromycin and nitrofur-
antoin increased between 1999 and 2005 (Table 1), whereas
the use of erythromycin, trimethoprim, phenethicillin,
doxycycline, cotrimoxazol and amoxicillin decreased.
Figure 2 shows the increase and decrease in the monthly
numbers of prescriptions per 1000 between 1999 and 2005.
The use of azithromycin, amoxicillin, erythromycin, clari-
thromycin and doxycyclin shows peaks around the winter
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months. Flucloxacillin has a different pattern with peaks
around August/September in 2002 and subsequent years.
There appears to be a difference between age categories
and sex in the year-prevalence of children receiving
systemic antibiotics. The mean prevalence during the 7-
year study period was 29.0% in the age group 0–4 years,
19.6% in the age group 5–9 years, 10.4% in the 10- to 14-
year-old group and 15.1% in the 15- to 19-year-old group.
In terms of gender, 17.3% of the boys and 19.9% of the
girls received at least one prescription per year. Although
there were some differences in the specific types of
antibiotic drugs (i.e. no doxycyclin in the youngest two
age groups and more drugs for urine tract infections in the
oldest age group), the trends in increased and decreased
prescribing in the period 1999 to 2005 remained the same
in all age categories, with one exception—trimethoprim.
There was a rapid decrease in the prescribing of this
antibiotic in the two younger age groups compared to the
two elder groups, as shown in Fig. 3. The use of
trimethoprim in the age groups 0–4 years and 5–9 years
decreased in the second half of 2004, and the use in the age
groups 10–14 years and 15–19 years remained approxi-
mately at the same level.
Discussion
Main results
Between 1999 and 2005 the yearly prevalence of antibiotic
use in children varied from 17.8 to 19.3%. The amount of
antibiotic prescriptions for children calculated on a monthly
basis fluctuated each year, with a peak around the winter
months. Although the total number of antibiotic prescrip-
tions per year did not change between 1999 and 2005, we
did observe a shift in prescribing patterns. The prescribing
of amoxicillin, the small-spectrum phenethicillin, which is a
penicillin preparation, and the older macrolide erythromy-
cin decreased, while the prescribing of amoxicillin with
clavulanic acid and the new macrolides azithromycin and
clarithromycin increased.
The use of flucloxacillin also showed an increasing
trend, especially during the months of August and
September. Trimethoprim was used less by the two younger
age groups. There was a general trend for antibiotic drug
use to be the highest in the youngest age group (0–4 years).

























Fig. 1 The 11 most prescribed drugs as proportions of the total
amount of oral antibiotic prescriptions (J01) for children ≤19 years old
Table 1 The number of pre-
scriptions for the most fre-
quently prescribed antibiotics
for children ≤19 years old per
1000 children for 2005 and
1999 and a comparison of
prescribing behaviour
expressed as a ratio (2005/
1999) of antibiotic drugs
prescribed
95% CI, 95% Confidence
interval











Azithromycin 8.87 15.82 1.78 (1.65–1.92)
Amoxicillin/clavulanic acid 17.90 30.37 1.70 (1.61–1.79)
Flucloxacillin 4.38 6.67 1.53 (1.37–1.71)
Clarithromycin 21.49 30.42 1.42 (1.34–1.49)
Nitrofurantoin 9.36 12.73 1.36 (1.26–1.47)
Decreased use
Erythromycin 13.90 4.92 0.35 (0.32–0.39)
Trimethoprim 18.43 13.01 0.71 (0.66–0.75)
Phenethicillin 19.88 15.21 0.76 (0.72–0.81)
Doxycylin 13.39 10.55 0.79 (0.73–0.85)
Cotrimoxazol 14.88 12.87 0.86 (0.81–0.93)
Amoxicillin 139.35 126.41 0.91 (0.89–0.93)
Miscellaneous antibiotic drugs 18.22 13.88 0.76 (0.71–0.81)
Total 300.05 292.89 0.98 (0.96–0.99)
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Fig. 2 Number of prescriptions per 1000 children in terms of 6-monthly increases or decreases in the number of antibiotics prescribed from 1999
until 2005
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Literature comparison
An Italian study of 1998, which concentrated on children
aged 0–15 years, showed that 46.4% of the children studied
received at least one antibiotic prescription in that year [14].
In Scotland in 1999/2000, the prevalence of antibiotic use
among 0- to 16-year olds was estimated at 14.2% [15]. In a
Danish study that was based on a prescription database, the
prevalence of antibiotic use was 29.0% in a group of 0- to
15-year olds. When we compare our data to those reported
in these studies, the prevalence of prescribing antibiotics to
children ≤19 years in the Netherlands is lower than that in
Italy, slightly lower than that in Denmark, but higher than
that in Scotland.
The study by Otters et al. is a cross-sectional study based
on the National GP Survey and restricted to 1987 and 2001
[9]. Data were presented for children aged 0–17 years, and
the yearly number of antibiotic prescriptions per 1000
children was determined. In 2001, this number was smaller
than what we found in 2001 (232 vs. 307). Possible
explanations for this difference could be the dissimilar age
groups or the fact that the origin of the data is not the same—
that is to say, GPs in the National Survey were aware of
participation, which may have influenced their prescribing
behaviour. However, our study shows that the trend described
by the Otters study (an increase in the number of broad-
spectrum antibiotic prescriptions) continued between 2001
and 2005.
The most commonly prescribed antibiotic drugs in our
study were amoxicillin, amoxicillin with clavulanic acid
and clarithromycin. This is comparable to the data obtained
in the National Survey from 2001 [9]. In Germany and
Denmark, the small-spectrum penicillin known as penicillin V
was prescribed more often for children than the broad-
spectrum penicillins [16, 17]. In Italy, cephalosporins and
macrolides were prescribed the most [14] and in Scotland,
amoxicillin, erythromycin and phenoxymethylpenicillin
were the most commonly prescribed antibiotics [15]. It
would appear that each country has its own preferences in
terms of antibiotic drugs.
In our study, the prevalence of antibiotic use was highest
in the youngest age group, and the lowest prevalence of
users was found in the group of 10- to 14-year olds. In the
National Survey, a similar distribution of antibiotic use was
found [9]. Studies from Italy and Denmark used different
age groups. Consequently, a direct comparison was not
possible [14, 17].
Seasonal variation
The fluctuations during the year in the number of
prescriptions per month peaking in the winter period and
showing a nadir in the summer is similar to the results of a
European study on adults [8] and possibly indicates that
most antibiotic drugs are prescribed for respiratory infec-
tions. Figure 2 shows precisely this pattern for drugs used
in treating respiratory infections (azithromycin, amoxicillin,
erythromycin, clarithromycin and doxycyclin). In contrast,
trimethoprim (Fig. 3), which is used for urinary tract
infections, does not show this kind of fluctuation.
The August and September peaks of flucloxacillin use
(Fig. 2) can be explained by an increase in the number of
impetigo cases in children in the Netherlands, which usually
occurs after the summer holiday when school starts again.
This phenomenon is described in a study by GPs [18].
Changes over time
The changes in the prescribing patterns between 1999 and
2005, which show an evolution in prescribing behaviour
from a preference for small-spectrum penicillin to one for
amoxicillin/clavulanic acid, and from older to newer
macrolides, have also been described in other Dutch studies
[9, 19]. This shift could be linked to a number of
circumstances. It is possible that the reports on increasing
antibiotic resistance encouraged physicians to choose a
broader and more safe approach to prescribing. The
decrease in the use of erythromycin may be attributed to
the fact that its use is associated with more side effects,
worse pharmacokinetic properties and increased interac-
tions with other drugs, in comparison to other macrolides.
Azithromycin has the additional advantage of requiring a
shorter course and having a more convenient dosage system
as a liquid formulation. Clarithromycin is currently avail-
able in straws, which allows the child to take the drug by
sucking it through the straw; this is a clever solution which
may also be preferred by the prescribing physician.
The decreased use of trimethoprim in the second half of
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Fig. 3 Number of prescriptions of trimethoprim per 1000 children per
month in different age categories
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by discontinuation of the product Monotrim, the only liquid
formulation of trimethoprim available in the Netherlands
[20]. There is an alternative in a pharmacy-based formula-
tion, however, this takes some time to prepare. According
to our results, most physicians choose to prescribe a
different antibiotic. Nitrofurantoin may be an alternative
to trimethoprim, but as this is not available as a liquid
formulation either, the physicians may prefer amoxicillin
with clavulanic acid or cotrimoxazole as an alternative for
these age groups.
Comparison to Dutch guidelines
Acute respiratory infections and otitis media are the most
frequently occurring infections in children. Data from the
National Survey showed that in 2001 the yearly incidence
of these two types of infections was 94.8 and 61.2 per 1000
children, respectively [21]. For a respiratory infection, both
Dutch guidelines, the NHG and GF, recommend prescrib-
ing small-spectrum phenethicillin only in the case of a
secondary bacterial infection. For otitis media, the preferred
drug is amoxicillin.
Before starting treatment, it is advised to wait for
3 days to see if there’s no improvement—except when
the patient is younger than 6 months. In case of a
penicillin allergy, the second choice for both indications
is clarithromycin [12, 13]. The large number of prescrip-
tions for amoxicillin in this study (137.9/1000 in 2001)
compared to those for phenethicillin (17.9/1000 in 2001),
which are relatively few, is not in accordance with the
indications for prevalence, suggesting that respiratory tract
infections are possibly not treated with the preferred drug.
It also appears that the guidelines' recommendation to
pursue a restrained policy towards antibiotic prescribing is
not being followed.
Accordingly, we conclude that the prescribing patterns in
terms of prescribing antibiotic drugs for Dutch children ≤
19 years old is not in agreement with the guidelines.
Limitations to the study
In this study the medical indications that motivated the
physician to prescribe the drugs were not known as this
information is generally not given to the pharmacy by
the physician. The prescriptions used here were only
dispensing data, so we did not know whether the patient
actually did use the medication at home. Our data are
merely an indication of how antibiotics are prescribed
and used.
The prophylactic use of antibiotics, the prolongation
of a course or the switch to another drug within a course
because of allergy or side effects were all counted as
separate prescriptions, even though they are actually part
of one episode of use. Of all prescriptions, 85% were not
followed by another antibiotic prescription within 1
month. Of the other 15%, some prescriptions may have
belonged to the same clinical episode, which would
suggest that we may have overestimated the number of
antibiotic courses.
Over-the-counter medication is not included in our
database. However, as antibiotic drugs are not allowed to
be sold over-the-counter in the Netherlands, this does not
represent a significant problem in our study.
Recommendations
The results of this study reveal that antibiotic prescribing
for children in the Netherlands is far from optimal, which is
similar to the situation in other countries.
Different ways have been investigated to improve
guideline-directed prescribing of antibiotic drugs in
children. One approach is to better educate the parents
in antibiotic use, including explanations during visits to
the doctor with the explicit aim of decreasing unneces-
sary prescribing [22–24]. Physicians could also be
trained more thoroughly in this area. A strategy imple-
mented in the UK—called ‘delayed prescribing’ (i.e. a
required delay of a few days before starting an antibiotic
course)—has reduced the prescribing rates for antibiotic
drugs without causing the number of hospital admissions
due to complications to increase [25–27]. The Dutch
guidelines already have recommended following this strate-
gy for otitis media [12]. The development of a clinical
decision rule for respiratory infections can reduce inappro-
priate prescribing of antibiotic drugs [6]. A similar decision
rule has been developed in public hospitals in Brazil, where
they look at the symptoms to separate viral and bacterial
respiratory infections, thereby preventing 41–55% of unnec-
essary antibiotic prescriptions.
Conclusion
On the basis of the results reported here, it would appear
that the image of the Netherlands being a country with a
restrained policy towards prescribing antibiotic drugs is
not entirely applicable when it concerns children. Not
only were broad-spectrum antibiotic drugs prescribed
more frequently than recommended by the guidelines,
but it also appears that a shift took place to broader
prescribing between the years 1999 and 2005. This is an
undesirable development as it could contribute to antibi-
otic resistance.
We found that the choice of drugs can be influenced by
events such as the unavailability of the drug as a liquid
formulation (thrimethoprim) or the increased occurrence of
a specific indication (impetigo and flucloxacillin).
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Our results demonstrate that an improvement of
guideline-directed antibiotic prescribing is needed in the
Netherlands.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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